Gomes Andre Spolidoro Ferreira sold 6,000 VTEX shares at $3.68 each across two transactions on 2026-09-16, leaving him with 30,400 shares. For investors, the reported 16.5% comparison shows the transaction’s stated size against his prior VTEX shareholding, while the disclosure identifies both the sale price and transaction structure.
Key Highlights
- Ferreira sold VTEX stock at $3.68 per share on 16 September 2026.
- The transaction covered 6,000 shares split across two sales.
- His remaining VTEX position was 30,400 shares, equal to about 16.5% of his prior holding.
Gomes Andre Spolidoro Ferreira sold 6,000 shares of VTEX in two transactions, reducing his reported position to 30,400 shares. The sales were carried out at $3.68 per share on 16 September 2026, according to the transaction details involving VTEX.
Two VTEX Sales Used Transaction Code S
The combined disposal covered 6,000 VTEX shares, and the stated price was $3.68 per share. The two trades took place on the same date, 16 September 2026.
Remaining VTEX Position Measures 30,400 Shares
Ferreira held 30,400 VTEX shares after the transactions. The reported 16.5% figure compares the sale with his prior shareholding in VTEX. That percentage is the stated measure of the transaction against his earlier position, while 30,400 shares is the balance reported after the sales.
FAQs
Q: How many VTEX shares did Gomes Andre Spolidoro Ferreira sell?
A: Gomes Andre Spolidoro Ferreira sold 6,000 VTEX shares in total. The reported disposition was split between two separate transactions on 16 September 2026.
Q: At what price did Ferreira sell VTEX shares?
A: The reported sale price was $3.68 per share on 16 September 2026. Both transactions carried SEC transaction code S for the VTEX stock sales.
Q: How many VTEX shares did Ferreira own after the transactions?
A: Ferreira owned 30,400 VTEX shares after completing the transactions.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.